Goldman Sachs Group Inc Organigram Holdings Inc. Transaction History

Goldman Sachs Group Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 May 14, 2024	BUY	$0.37 - $0.69 $17,703 - $33,015	47,848 Added 38.92%	170,777 $66,000
Q2 2023 Aug 14, 2023	BUY	$0.37 - $0.69 $17,703 - $33,015	47,848 Added 38.92%	170,777 $66,000
Q1 2023 May 14, 2024	SELL	$0.6 - $0.99 $189,462 - $312,613	-315,771 Reduced 71.98%	122,929 $78,000
Q1 2023 May 11, 2023	SELL	$0.6 - $0.99 $189,462 - $312,613	-315,771 Reduced 71.98%	122,929 $78,000
Q4 2022 May 14, 2024	SELL	$0.7 - $1.19 $21,589 - $36,701	-30,842 Reduced 6.57%	438,700 $350,000
Q4 2022 Feb 13, 2023	SELL	$0.7 - $1.19 $21,589 - $36,701	-30,842 Reduced 6.57%	438,700 $350,000
Q3 2022 May 14, 2024	SELL	$0.87 - $1.24 $201,471 - $287,154	-231,576 Reduced 33.03%	469,542 $409,000
Q3 2022 Nov 10, 2022	SELL	$0.87 - $1.24 $201,471 - $287,154	-231,576 Reduced 33.03%	469,542 $0
Q2 2022 May 14, 2024	BUY	$0.92 - $1.81 $645,028 - $1.27 Million	701,118 New	701,118 $642,000
Q2 2022 Aug 15, 2022	SELL	$0.92 - $1.81 $168,790 - $332,077	-183,468 Reduced 20.74%	701,118 $642,000
Q1 2022 May 16, 2022	BUY	$1.3 - $1.83 $666,412 - $938,103	512,625 Added 137.82%	884,586 $1.47 Million
Q4 2021 Feb 14, 2022	BUY	$1.75 - $2.48 $349,888 - $495,841	199,936 Added 116.22%	371,961 $651,000
Q3 2021 Nov 10, 2021	BUY	$2.3 - $2.94 $395,657 - $505,753	172,025 New	172,025 $396,000

7.38M

Ticker OGI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 313,708,000
Market Cap $568M
Description
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, ...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.